Eli Lilly and Co (NYSE:LLY)

73.58
Delayed Data
As of Mar 27
 +0.14 / +0.19%
Today’s Change
57.17
Today|||52-Week Range
77.46
+6.65%
Year-to-Date
City accused of failing to back life sciences sector
10:15am / FT.com
Notable 52-Week Highs and Lows 3/23: (PFE) (TEVA) (DRI) High; (MEIP) (SONS) (YOKU) Lo...
Mar 23 / Investing Channel
Indiana backlash: Opposition to anti-gay law grows
Mar 28 / CNNMoney.com
Drug Companies Go in Opposite Directions
Mar 23 / TheStreet.com
5 Freakishly Expensive Cancer Drugs
Mar 28 / MotleyFool.com
Drug Companies in Opposite Directions
Mar 23 / TheStreet.com
Insulin: moving the needle
Mar 27 / FT.com
3 Drugs Stocks Moving The Industry Upward
Mar 23 / TheStreet.com
Apple's Tim Cook 'deeply disappointed' in Indiana's anti-gay law
Mar 27 / CNNMoney.com
3 Biotech ETFs in Focus as Biogen Soars - ETF News And Commentary
Mar 23 / Zacks.com
Indiana signs 'religious freedom' bill
Mar 26 / FT.com
Why ImmunoGen Inc. is Soaring Higher Today
Mar 23 / MotleyFool.com
3 Stocks Reiterated As A Buy: PFE, LLY, AA
Mar 26 / TheStreet.com
3 Big Pharma Stocks Wall Street Is Wrong About
Mar 23 / MotleyFool.com
Insider Trading Alert - PRE, NNN And LLY Traded By Insiders
Mar 25 / TheStreet.com
Eli Lilly Collaborates with Korean Hanmi Pharmaceutical - Analyst Blog
Mar 20 / Zacks.com
Pfizer & Eli Lilly to Resume Phase III Study of Tanezumab - Analyst Blog
Mar 24 / Zacks.com
Biogen's Alzheimer's drug shows early promise
Mar 20 / FT.com
A Healthy Dose of Biogen
Mar 24 / TheStreet.com
Pharma Stock Outlook: Let's Make a Deal - Industry Outlook
Mar 17 / Zacks.com
Eli Lilly Partners with Innovent to Develop Oncology Drugs - Analyst Blog
Mar 23 / Zacks.com
Pharma Stock Outlook: Let's Make a Deal - Zacks Analyst Interviews
Mar 17 / Zacks.com
Biogen Gains on Positive Alzheimer's Drug Interim Results - Analyst Blog
Mar 23 / Zacks.com
Where Is Radius Health Now?
Mar 17 / MotleyFool.com
How Lilly and Amgen Are Going in Opposite Directions
Mar 23 / TheStreet.com
Dementia research boosted by $100m venture capital fund
Mar 16 / FT.com
Eli Lilly (LLY) Stock Gains Today After FDA Lifts Ban on Pain Treatment Drug Trials
Mar 23 / TheStreet.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account